Description
A sesquiterpene; inhibits CYP2C9 (Ki = 1.26 μM); reduces Pck1 and G6pc gene expression, cAMP concentration, and CREB phosphorylation, increases PDE3 activity, and inhibits gluconeogenesis in rat primary hepatocytes; decreases serum and hepatic triglyceride levels, as well as random-fed and fasting blood glucose levels in ob/ob mice
Formal name: (1aS,4E,10S,10aS)-3,6,10,10a-tetrahydro-5,9-dimethyl-2H-10,1a-(epoxymethano)oxireno[4,5]cyclodeca[1,2-b]furan-12-one
Synonyms:
Molecular weight: 260.3
CAS: 13476-25-0
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Natural Products|Terpenes||Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Toxicology|Drug Metabolism|Cytochrome P450